Sean Durigan

Sean Durigan is a seasoned professional in the biopharmaceutical industry, currently serving as Senior Manager of DS MSAT at Keros Therapeutics since April 2024. Previous experience includes roles as Senior Process Engineer at Generation Bio, where Sean led the MS&T team in scaling up non-viral gene therapy production, and BioProcess Engineer II at Novartis Gene Therapies, focusing on cGMP downstream manufacturing of AAV-based gene therapy. Sean's career also encompasses manufacturing and operational roles at AstraZeneca and AlloSource, emphasizing compliance with GMP standards and process optimization. Educational background includes a Bachelor of Science in Cell/Cellular and Molecular Biology from the University of Illinois Urbana-Champaign.